Ocushield commits to raising £10,000 for the RNIB
The company will donate £1 from every sale of blue light filter products made through Ocushield.com
2 min read
Getty/ipopba
17 September 2020
Ocushield has revealed its plans to raise £10,000 for the Royal National Institute for Blind People (RNIB) through a new partnership.
The company is the creator of the world’s first medically approved blue light filter, and has committed to donating £1 from every sale of the product through its website.
The donations will support the RNIB’s Tech for Life programme, which facilitates help and support for those with sight loss who want to become confident in their use of technology.
Ocushield offers various products that contain a blue light filter, including eyewear options in three new styles and three colourways, which were launched in August this year. The company is also launching an anti-bacterial blue light screen protector ahead of this autumn’s release of the iPhone 12.
Dhruvin Patel, optometrist and founder of Ocushield, said: “We want to support the RNIB’s crucial role in creating a world where there are no barriers to people with sight loss – and we want to encourage society, communities and individuals to see differently.”
Matt Stringer, CEO of RNIB, emphasised that “modern technology is a vital force in transforming the lives of blind and partially sighted people for the better. It can cover every aspect of their lives, from listening to audio books, to using screen readers and voice-enabled services on their mobiles to send messages and emails.”
He added: “We want more and more people with sight loss to appreciate the benefits of technology and how it can help them travel, work, connect with others, enjoy pastimes independently and much more.
“With Ocushield’s support, we have more help to change that. Together we can ensure more blind and partially sighted people can benefit from technology.”
Donations are made through purchases of the blue light filter made via ocushield.com
The company is the creator of the world’s first medically approved blue light filter, and has committed to donating £1 from every sale of the product through its website.
The donations will support the RNIB’s Tech for Life programme, which facilitates help and support for those with sight loss who want to become confident in their use of technology.
Ocushield offers various products that contain a blue light filter, including eyewear options in three new styles and three colourways, which were launched in August this year. The company is also launching an anti-bacterial blue light screen protector ahead of this autumn’s release of the iPhone 12.
Dhruvin Patel, optometrist and founder of Ocushield, said: “We want to support the RNIB’s crucial role in creating a world where there are no barriers to people with sight loss – and we want to encourage society, communities and individuals to see differently.”
Matt Stringer, CEO of RNIB, emphasised that “modern technology is a vital force in transforming the lives of blind and partially sighted people for the better. It can cover every aspect of their lives, from listening to audio books, to using screen readers and voice-enabled services on their mobiles to send messages and emails.”
He added: “We want more and more people with sight loss to appreciate the benefits of technology and how it can help them travel, work, connect with others, enjoy pastimes independently and much more.
“With Ocushield’s support, we have more help to change that. Together we can ensure more blind and partially sighted people can benefit from technology.”
Donations are made through purchases of the blue light filter made via ocushield.com
Advertisement
More Charity articles
-
Childhood Eye Cancer Trust launches new online resources for young people affected by retinoblastoma
-
Macular Society partners with Ora to increase participation in clinical research
-
Deafblind UK wins ScottishPower Foundation Education Award
-
Works by deafblind artist for sale as NFTs to celebrate awareness week
Comments (0)
You must be logged in to join the discussion. Log in